The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factors in patients with advanced thymic carcinoma treated with chemotherapy: a retrospective analysis of 289 patients from NEJ023 Study.
 
Yusuke Okuma
No Relationships to Disclose
 
Ryo Ko
Honoraria - AstraZeneca Japan; Boehringer Ingelheim
 
Takehito Shukuya
Honoraria - AstraZeneca; Chugai Pharma; Lilly; Pfizer
 
Kazunari Tateishi
No Relationships to Disclose
 
Hisao Imai
No Relationships to Disclose
 
Eisaku Miyauchi
No Relationships to Disclose
 
Akiko Fujiwara
No Relationships to Disclose
 
Tomohide Sugiyama
No Relationships to Disclose
 
Keisuke Azuma
No Relationships to Disclose
 
Keiko Muraki
No Relationships to Disclose
 
Masahiro Yamasaki
No Relationships to Disclose
 
Hisashi Tanaka
No Relationships to Disclose
 
Yuta Takashima
No Relationships to Disclose
 
Sayo Soda
No Relationships to Disclose
 
Osamu Ishimoto
No Relationships to Disclose
 
Nobuyuki Koyama
Honoraria - Boehringer Ingelheim; Chugai Pharma; Lilly Japan
 
Shoichi Kuyama
Honoraria - AstraZeneca Japan; Boehringer Ingelheim; Chugai Pharma; Meiji Seika Kaisha; Taiho Pharmaceutical
 
Kyoko Murase
No Relationships to Disclose
 
Satoshi Morita
No Relationships to Disclose
 
Kazuhisa Takahashi
Research Funding - Astellas Pharma (Inst); AstraZeneca Japan (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Kyorin (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)